Veriskin, Inc.
Veriskin is a medical device company dedicated to facilitating and improving the accuracy of skin cancer screening
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location San Diego, CA, USA
- Currency USD
- Founded May 2016
- Employees 4
- Incorporation Type C-corp
- Website veriskin.com
Company Summary
The TruScore is a proprietary, non-invasive, low-cost, hand-held device that aids a non-expert user to rapidly and objectively determine whether a suspect skin lesion is cancerous. The patent pending technology works by detecting pathological angiogenesis which is a well established hallmark of cancer. The device is intended to be used as a decision support tool for non-specialists, e.g. primary care physicians and nurse practitioners.
Team
-
CEO/CTO -
Carl F. EdmanCo-founder, Board MemberExperienced early stage medical device executive, co-founder of PhiloMetron (wireless medical devices) and Corventis (acquired by Medtronics $150MM). Strategy and business advisor to multiple entities including Topera (acquired by Abbott $250MM).
-
Eugene TuCo-founder, Board MemberFounding team member of multiple biotech startups (Nanogen, Genoptix, Nanomix, Omniome) and consultant to early and growth stage biotech companies. Thirty years’ experience converting research ideas to CLIA and FDA approved products in genomics & diagnostics.
-
Autumn Lang, Ph.D.VP Clinical AffairsEdwards Lifesciences, QmedConsulting ApS, coramazetechnologies GmbH, confinisCPM ag, ClinlogixEurope GmbH
-
Raj KhoshooChief Development OfficerRaj Khoshoo has 40+ years at Siemens where he focused on developing disruptive strategic partnerships that extended Siemens reach in product portfolio, market reach and technology footprint. Currently also a partner at Sum Ventures
Advisors
-
Monica WellingUnconfirmed
Michael Wang MDUnconfirmed
Previous Investors
-
Jay RobertsUnconfirmed -
BOBBA VENKATADRIUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.